Haemonetics (HAE) Launches SafeTrace Tx In North America
Zacks Investment Research | Dec 03, 2019 09:12PM ET
Haemonetics Corporation (NYSE:HAE) announced the commercial availability of its SafeTrace Tx transfusion management software, a blood bank information system (BBIS), in North America. The next-generation offering is user friendly and has a contemporary look. It also helps elevate transfusion safety, interoperability, workflow efficiency and continuity of care.
Per the company, most hospitals use SafeTrace Tx as it supports safe, efficient and effective blood bank operations. The company expects to build on this momentum as interoperability and analytics are continuously gaining importance in Hospital Information Systems.
With the latest commercial release, Haemonetics aims to strengthen its hospital business’ transfusion management products.
Few Words on the Product
SafeTrace Tx is a specialized transfusion management system used in blood banks to manage patient and blood product information. It also aids in determining the suitability of blood products for transfusions.
The company believes that SafeTrace Tx, which has been designed based on input from experienced blood bankers, will greatly enhance data visualizations and analytics.
Recent Developments in Hospital Business
Of late, Haemonetics has been witnessing robust growth in its hospital business’ transfusion management segment.
The company commercially released TEG 6s PlateletMapping ADP (NASDAQ:ADP) & AA assay cartridge in November. The four-channel cartridge is intended for use with TEG 6s Hemostasis Analyzer System, which was cleared by the FDA in May for expanded use in adult trauma cases. Notably, the TEG 6s Hemostasis Analyzer System received the CE Mark and is available globally.
Industry Prospects
Per a report by Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.